Annual ROE
-142.50%
-66.18%-86.71%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual return on equity is -142.50%, with the most recent change of -66.18% (-86.71%) on December 31, 2023.
- During the last 3 years, CMMB annual ROE has fallen by -87.41% (-158.67%).
- CMMB annual ROE is now -601.97% below its all-time high of -20.30%, reached on December 31, 2021.
Performance
CMMB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-101.70%
+9.90%+8.87%
September 1, 2024
Summary
- As of February 8, 2025, CMMB quarterly return on equity is -101.70%, with the most recent change of +9.90% (+8.87%) on September 1, 2024.
- Over the past year, CMMB quarterly ROE has increased by +9.90% (+8.87%).
- CMMB quarterly ROE is now -494.04% below its all-time high of -17.12%, reached on June 30, 2021.
Performance
CMMB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CMMB ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -86.7% | +8.9% |
| 3 y3 years | -158.7% | +8.9% |
| 5 y5 years | -158.7% | +8.9% |
CMMB ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -602.0% | at low | -409.8% | +8.9% |
| 5 y | 5-year | -602.0% | at low | -494.0% | +8.9% |
| alltime | all time | -602.0% | at low | -494.0% | +8.9% |
Chemomab Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -101.70%(-8.9%) |
| Jun 2024 | - | -111.60%(+0.7%) |
| Mar 2024 | - | -110.87%(+2.1%) |
| Dec 2023 | -142.50%(+86.7%) | -108.55%(+7.2%) |
| Sep 2023 | - | -101.23%(+0.1%) |
| Jun 2023 | - | -101.15%(+29.8%) |
| Mar 2023 | - | -77.93%(+33.8%) |
| Dec 2022 | -76.32% | -58.23%(+28.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -45.38%(+38.8%) |
| Jun 2022 | - | -32.70%(+29.9%) |
| Mar 2022 | - | -25.18%(+26.2%) |
| Dec 2021 | -20.30%(-63.2%) | -19.95%(+5.9%) |
| Sep 2021 | - | -18.83%(+10.0%) |
| Jun 2021 | - | -17.12%(-5.3%) |
| Mar 2021 | - | -18.07%(-67.2%) |
| Dec 2020 | -55.09% | -55.09% |
FAQ
- What is Chemomab Therapeutics annual return on equity?
- What is the all time high annual ROE for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual ROE year-on-year change?
- What is Chemomab Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly ROE year-on-year change?
What is Chemomab Therapeutics annual return on equity?
The current annual ROE of CMMB is -142.50%
What is the all time high annual ROE for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual return on equity is -20.30%
What is Chemomab Therapeutics annual ROE year-on-year change?
Over the past year, CMMB annual return on equity has changed by -66.18% (-86.71%)
What is Chemomab Therapeutics quarterly return on equity?
The current quarterly ROE of CMMB is -101.70%
What is the all time high quarterly ROE for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly return on equity is -17.12%
What is Chemomab Therapeutics quarterly ROE year-on-year change?
Over the past year, CMMB quarterly return on equity has changed by +9.90% (+8.87%)